PCS Deleted Code XW023X7
Deleted code, effective
Sep. 30, 2026
Get the full picture on this code.
Start a FREE 2-WEEK TRIAL of Codify by AAPC.
Official Code Descriptor
Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
Additional/Related Information
Tabs
| Section(X) | Body System(W) | Operation(0) | Approach(3) | Qualifier(7) | Body Part(2) | Device / Substance / Technology(X) |
| New Technology | Anatomical Regions | Introduction | Percutaneous | New Technology Group 7 | Muscle | Broad Consortium Microbiota-based Live Biotherapeutic Suspension |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Deleted | 09-30-2026 | Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 |
| Code Added | 10-01-2021 |
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.
